Technically speaking this shouldn’t be allowed…. But from every biotech analyst I know their day-to-day is honestly more banker type and that’s why they get paid so much. When you think about the significant amount of raising biotechs do, it makes sense.
Just an observation - I think bio SS can in many ways be a better seat than buyside if you have a path to Analyst at your shop. Thinking risk/reward here
| +33 | Breaking into BB ER from Brown | 11 | 4h | |
| +31 | MM Equity Research--Concerned | 18 | 1d | |
| +29 | Advice needed: Do you value your own coverage or brand clout more? | 8 | 2w | |
| +23 | Is it really that bad? | 23 | 1w | |
| +19 | Laid off IB Analyst: Go to ER or Pod? | 18 | 1w | |
| +17 | Best way to break into Biotech ER? | 10 | 1w | |
| +16 | Biotech stock pitch - where do you start? | 16 | 2w | |
| +16 | Analysis of Ulta Beauty | 1 | 3w | |
| +15 | Navigating Equity Research Career Path with a Unique Background - Seeking Advice | 2 | 3w | |
| +14 | Advice Needed: Independent research to build experience | 2 | 2w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Source? Can you elaborate?
Bump can u elaborate
Bump
There are lots of small biotech companies that frequently raise capital, are taken out, etc… These companies may not be worth covering from an investor interest perspective, but might be worth the bank covering strictly from a banking relationship perspective. A lot of times, these covering analysts are “brought over the wall” in deal processes… and are instrumental in allowing deals to get across the line, which is a significant element of their value proposition to the bank.
I’m not sure I’d call them pseudo-bankers as the work they do is not banking work (that’s not their day-to-day, they aren’t structuring deals or anything like that), but I kind of see where you’re coming from.
Voluptas illo saepe asperiores adipisci itaque adipisci eos maiores. Ea tempora perferendis placeat id.
Perspiciatis et alias cupiditate eligendi omnis. Velit et dignissimos est ex ut. Non inventore quae quod voluptate quod id eos. Aut omnis sapiente velit et quibusdam voluptate consectetur. Totam eum perferendis quia adipisci. Tempore nesciunt dolorem autem labore libero dicta quam velit.
Nesciunt soluta minus quod cupiditate debitis. Minima omnis vitae nam tenetur totam aliquam. Id sint provident ea est est. Nihil omnis saepe doloremque ut.
Dolor doloribus provident voluptatem et quo est vero. Dolores doloremque vel illum est quia est. Sed qui magnam dolorum doloremque incidunt harum cum hic. Et autem placeat eius consequatur quisquam voluptatem. Error est quae incidunt mollitia aspernatur delectus. Voluptas totam ut officia et nesciunt non. Tempore perferendis ducimus perferendis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...